← Open Payments lookup

RALPH HADLEY: Open Payments

NPI 1295959211 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,021 in 44 payments from 18 companies in 2025. Trend: 2023 $726 · 2024 $959 · 2025 $1,021

Food & beverage: $1,021
CompanyPaymentsAmount
Novo Nordisk Inc8$227
AstraZeneca Pharmaceuticals LP7$150
Axsome Therapeutics, Inc.4$107
Boehringer Ingelheim Pharmaceuticals, Inc.3$74
Lilly USA, LLC3$72
ABBVIE INC.2$55
Merck Sharp & Dohme LLC2$52
Dexcom, Inc.2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Takeda Pharmaceuticals U.S.A., Inc.2$37

Products named: Rybelsus, AIRSUPRA, JARDIANCE, Auvelity, VRAYLAR, Dexcom G6 Transmitter, CAPLYTA, TRINTELLIX.

Industry payments across TX — which companies pay providers there.